revenues expected from FY26 - Cenexi turnaround on track, new vaccine/ampoule/syringe lines to drive FY26 growth - R&D spend: 192 Cr in FY25 (~4.7% of revenue) Follow Harshal Jain for the latest insights into the healthcare world
Note: It is vital to consult with a licensed professional
Wyobra sobie, e wchodzi do miasteczka komrek i jednoczenie wysya wiadomo listonoszowi, straakom, mechanikom i ogrodnikom
This gradual escalation continues in 2.5 mg increments through 7.5 mg, 10 mg, 12.5 mg, and up to the maximum dose of 15 mg per week
GLP-1R agonists reduce food intake by triggering both aversive or emetic neural and satiety signals which are dissociable in rodents (7376)
Throughout, I'll use the generic drug names, because the brands differ by country